Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.26.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Condensed Balance Sheet
The tables below provide information about the adjustments as of and for the three months ended March 31, 2025.
March 31, 2025
Unaudited Condensed Consolidated Balance Sheet As Previously Reported Adjustments Revised
Other accrued expenses $ 21,985  $ 1,840  $ 23,825 
Total current liabilities $ 161,730  $ 1,840  $ 163,570 
Total liabilities $ 203,291  $ 1,840  $ 205,131 
Additional paid-in capital $ 576,758  $ 1,559  $ 578,317 
Accumulated deficit $ (558,761) $ (3,399) $ (562,160)
Total stockholders’ equity $ 5,555  $ (1,840) $ 3,715 
Total liabilities and stockholders’ equity $ 208,846  $ —  $ 208,846 
Three Months Ended March 31, 2025
Unaudited Condensed Consolidated Statements of Operations As Previously Reported Adjustments Revised
Cost of revenue $ 15,092  $ 72  $ 15,164 
Gross profit $ 8,784  $ (72) $ 8,712 
Research and development $ 8,509  $ 150  $ 8,659 
Sales and marketing $ 4,735  $ 796  $ 5,531 
General and administrative $ 15,810  $ 1,840  $ 17,650 
Total operating expenses $ 34,214  $ 2,786  $ 37,000 
Loss from operations $ (25,430) $ (2,858) $ (28,288)
Loss before income taxes $ (20,663) $ (2,858) $ (23,521)
Net loss $ (20,657) $ (2,858) $ (23,515)
Loss per share:
Basic $ (0.77) $ (0.11) $ (0.88)
Diluted $ (0.77) $ (0.11) $ (0.88)
Schedule of Cash and Cash Equivalents
The following table shows components of cash, cash equivalents, and restricted cash reported on the condensed consolidated balance sheets and in the condensed consolidated statements of cash flows as of the dates indicated:
September 30,
2026
December 31,
2025
Cash and cash equivalents $ 30,902  $ 24,813 
Restricted cash included in other long-term assets 562  579 
$ 31,464  $ 25,392 
Schedule of Restricted Cash
The following table shows components of cash, cash equivalents, and restricted cash reported on the condensed consolidated balance sheets and in the condensed consolidated statements of cash flows as of the dates indicated:
September 30,
2026
December 31,
2025
Cash and cash equivalents $ 30,902  $ 24,813 
Restricted cash included in other long-term assets 562  579 
$ 31,464  $ 25,392 
Schedules of Concentration of Risk, by Risk Factor
The Company also operates globally, and a substantial portion of its assets are located in certain geographic regions. The allocation of the Company’s assets by region was as follows:
September 30,
2026
December 31,
2025
EMEA
United Kingdom 32  % 33  %
Germany 24  % 23  %
Luxembourg 17  % 17  %
73  % 73  %
Americas
U.S. 27  % 27  %
27  % 27  %
Total 100  % 100  %
The following customers represented 10% or more of the Company’s total revenue and total accounts receivable for each of the following periods:
Three Months Ended September 30, Nine Months Ended September 30,
Revenue: 2026 2025 2026 2025
Customer A (1)
29 % 35 % 27 % 21 %
Customer B 31 % 13 % 19 % 10 %
Customer C 12 % * 12 % *
Customer D * * * 10 %
Accounts Receivable: September 30,
2026
December 31,
2025
Customer E 33 % *
Customer F 10 % *
Customer G * 34 %
Customer H * 11 %
(1)Consists of multiple U.S. government agencies, of which one government agency represented greater than 10% of total revenue for each of the three and nine months ended September 30, 2026. One government agency represented greater than 10% of total revenue for the three months ended September 30, 2025. No government agency represented greater than 10% of total revenue for the nine months ended September 30, 2025.
*Revenue from customer was less than 10% of total revenue during the applicable period or accounts receivable from customer were less than 10% of total accounts receivable as of the applicable period.